Joan Bladé, M.D
Hospital Clinic, Hematology
IMF Scientific Advisory Board
Prof. Bladé graduated from the Medical School of the University of Barcelona. In 1981 he joined the staff at the Hematology Department of Hospital Clinic, where is now the Senior Consultant and Director of the Myeloma Programs. He was co-founder of the PETHEMA Foundation, and co-founder of the Spanish Myeloma Group. Dr. Bladé chaired the group who developed the European Group and Marrow Transplantation (EBMT) response criteria, known today as the Blade Criteria. He has published over 200 papers on both myeloma and MGUS, and he is an active member of the International Myeloma Working Group (IMWG).
Dr. Bladé is the recipient of the 2010 Robert A. Kyle Lifetime Achievement Award.